Albany, New York, December 14, 2016: The vast rise in the global prevalence of cancer and the resultant rise in cases of radiation-induced dermatitis due to the frequent radiation treatments undergone by cancer patients has necessitated the easy availability of effective radiodermatitis treatment options globally. In a detailed market research report recently featured on Market Research Reports Search Engine (MRRSE), it has been noted that the demand for radiodermatitis treatment options will soar in the near future as cancer cases will continue to rise at an alarming pace.
The report is titled “Radiodermatitis Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016–2024.” The radiodermatitis market opportunity on a global front is poised to rise from a valuation of US$299.6 mn in 2015 to US$421.5 mn by 2024, exhibiting a moderate 3.9% CAGR over the period between 2016 and 2024.
The report states that innovation in product offering will be the key for sustainable returns on investment for companies operating in the global radiodermatitis market. The immense pain experienced post radiology treatments and the poor quality of life thus rendered are compelling patients to look for new and more convenient treatment options. This scenario will act as a driver for innovation in the market and companies focusing on this factor will gain a better control on the market.
The report segments the global radiodermatitis market on the basis of three broad criteria: product type, distribution channel, and geography.
On the basis of product type, the market is segmented into topical agents, oral medication, and dressings. Of these, the segment of topical agents includes radiodermatitis treatment products that are most prescribes by healthcare practitioners as well as are most preferred by consumers. The segment held a nearly 70% of the overall market in 2015 and is expected to exhibit a 4.2% CAGR from 2016 through 2024, higher than other product varieties.
Thus, the segment of topical agents will continue to dominate the global radiodermatitis market over the near future as well. The segment of oral medications holds a miniscule share in the global market and is expected to further lose share by the end of the report’s forecast period.
In terms of distribution channel, the market has been segmented into hospital pharmacy, online store, and retail pharmacy store. Of these, the segment of retail pharmacy store dominated the global market in 2015, followed closely by the segment of online stores. The report states that a multichannel approach works better in the market for radiodermatitis treatments as the onset of the condition can occur either during the radiation therapy or after it.
Browse Full Global Radiodermatitis Market Report with TOC:http://www.mrrse.com/radiodermatitis-market
In terms of geography, the market for radiodermatitis in Asia Pacific dominated, accounting for over 45% of the overall market in 2015. Over the report’s forecast period as well, Asia Pacific, along with another key developing region: Latin America, will lead to the most lucrative returns on investment owing to a high growth pace of nearly 4% CAGR from 2016 through 2024.
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
90, State Street
Albany, NY – 12207